Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Treatment
1770 results:

  • 1. [Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
    Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
    Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A cross-sectional study of sleep disturbance among middle-aged cancer patients at Vietnam National cancer Hospital.
    Pham AT; Do MT; Tran HTT
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2055. PubMed ID: 38577715
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Strassmann V; Wexner SD
    Int J Colorectal Dis; 2024 Mar; 39(1):43. PubMed ID: 38538931
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
    Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
    J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trials.
    Benjamin DJ; Haslam A; Prasad V
    Cancer Med; 2024 Mar; 13(5):e7049. PubMed ID: 38491813
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial.
    Lenz HJ; Parikh A; Spigel DR; Cohn AL; Yoshino T; Kochenderfer M; Elez E; Shao SH; Deming D; Holdridge R; Larson T; Chen E; Mahipal A; Ucar A; Cullen D; Baskin-Bey E; Kang T; Hammell AB; Yao J; Tabernero J
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38485190
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.
    Yan H; Song L; Li Y; Xu Q; Guo W; Lin S; Jiang W; Wang Z; Deng L; Huang Z; Qin H; Zhang X; Tong F; Zhang R; Liu Z; Zhang L; Yu J; Dong X; Gong Q; Deng J; Chen X; Wang J; Zhang G; Yang N; Zhang Y; Zeng L
    Cancer Immunol Immunother; 2024 Mar; 73(4):74. PubMed ID: 38451314
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Synergic actions of botulinum neurotoxin A and oxaliplatin on colorectal tumour cell death through the upregulation of TRPM2 channel-mediated oxidative stress.
    Demir S; Duman İ; Nazıroğlu M
    Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13844. PubMed ID: 38350599
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate cancer.
    Boiarsky D; Gulhan DC; Savignano H; Lakshminarayanan G; McClure HM; Silver R; Hirsch MS; Sholl LM; Choudhury AD; Ananda G; Park PJ; Tewari AK; Berchuck JE
    Clin Genitourin Cancer; 2024 Apr; 22(2):558-568.e3. PubMed ID: 38342659
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Herbal medicine for the prevention of chemotherapy-induced nausea and vomiting in patients with advanced colorectal cancer: A prospective randomized controlled trial.
    Wu Z; Fu X; Jing H; Huang W; Li X; Xiao C; Li Z; You F
    J Ethnopharmacol; 2024 May; 325():117853. PubMed ID: 38341113
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Neoadjuvant Immunotherapy With Ipilimumab Plus Nivolumab in Mismatch Repair Deficient/Microsatellite Instability-High colorectal cancer: A Preliminary Report of Case Series.
    Pan T; Yang H; Wang WY; Rui YY; Deng ZJ; Chen YC; Liu C; Hu H
    Clin Colorectal Cancer; 2024 Mar; 23(1):104-110. PubMed ID: 38336555
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association of a novel frameshift variant and a known deleterious variant in MMR genes with Lynch syndrome in Chinese families.
    Li J; Ni H; Wang X; Cheng W; Li L; Cheng Y; Liu C; Li Y; Deng A
    World J Surg Oncol; 2024 Jan; 22(1):36. PubMed ID: 38280988
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Salvage treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality Therapy.
    Damron EP; McDonald J; Rooney MK; Das P; Ludmir EB; Minsky BD; Messick C; Chang GJ; Morris VK; Holliday EB
    Clin Colorectal Cancer; 2024 Mar; 23(1):85-94. PubMed ID: 38216367
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Patient-Reported Financial Burden of treatment for Colon or Rectal cancer.
    Kircher S; Duan F; An N; Gareen IF; Sicks JD; Sadigh G; Suga JM; Kehn H; Mehan PT; Bajaj R; Hanson DS; Dalia SM; Acoba JD; Yasar DG; Park ER; Wagner LI; Carlos RC
    JAMA Netw Open; 2024 Jan; 7(1):e2350844. PubMed ID: 38194233
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial.
    Coffman-D'Annibale K; Myojin Y; Monge C; Xie C; Hrones DM; Wood BJ; Levy EB; Kleiner D; Figg WD; Steinberg SM; Redd B; Greten TF
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38184304
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. UGT1A1 genotype-guided irinotecan dosing during neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A prospective analysis of SN-38 concentration.
    Jiang PC; Wang SW; Li C; Fan J; Zhu J
    Int J Cancer; 2024 Apr; 154(8):1484-1491. PubMed ID: 38158593
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of Geriatric Nutritional Risk Index With Adverse Event and treatment Duration in Adjuvant Chemotherapy for Patients With colorectal cancer.
    Shimizu A; Fukasawa M; Endo R; Nakamura T; Yamada S; Fujibayashi R; Kikuchi K; Tanaka M; Hasegawa I; Sato H
    In Vivo; 2024; 38(1):453-459. PubMed ID: 38148079
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immunotherapy in rectal cancer patients-a propensity score matched analysis of the National cancer Database.
    Horesh N; Emile SH; Freund MR; Garoufalia Z; Gefen R; Nagarajan A; Wexner SD
    Int J Colorectal Dis; 2023 Dec; 39(1):8. PubMed ID: 38133666
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic colorectal Adenocarcinoma.
    Dayyani F; Balangue J; Valerin J; Keating MJ; Zell JA; Taylor TH; Cho MT
    Clin Colorectal Cancer; 2024 Mar; 23(1):67-72. PubMed ID: 38103947
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [A study on the surgical efficacy of modified laparoscopic levator ani muscle external abdominoperineal resection for the treatment of ultra-low rectal cancer patients].
    Xing YG; Sun H; Guo DX; Zai SF; Xue L
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(46):3776-3780. PubMed ID: 38092555
    [No Abstract]    [Full Text] [Related]  


    of 89.